Similar effects of the inhibition of NF-κB on cell cycle arrest at the G2/M phase have been reported in lymphoma [28], [29], Non-Small-Cell Lung Cancer [30] and leukemia cells [31]. The gene discussed is NFKB1; the disease is lymphoma.